Mainz, Germany – Effective April 1, 2017, Dr. Michael Bartels, VP Operations, will strengthen the executive management of ORGENTEC Diagnostika GmbH.
Managing Director and CFO Ralf Wehen takes this as an important step in the further development of the company: "With this decision, we are securing our strategic position in the market, creating reliability and stability for our customers, partners and employees.
I look forward to continued work with our new Managing Director Dr. Bartels.
Together, we will lead ORGENTEC successfully into the future. We are proud to have gained such an experienced manager for our management - his international perspective on the medical technology market is a valuable asset for us."
About ORGENTEC
Headquartered in Mainz, Germany, ORGENTEC Diagnostika offers one of the industry’s most comprehensive portfolios in autoimmune diagnostics and cardiovascular diagnostics with additional strengths in infectious disease and organ function testing. Alegria®, the automated instrument for autoimmune and infectious disease serology enables labs to complete multiple assays and deliver faster results at minimum cost. With subsidiaries in Austria, Hungary, France, U.S. and China, as well as an established global network of distribution partners, ORGENTEC’s products are benefitting patients in over 100 countries around the world.
{text}